Avanos Medical (AVNS) Liabilities from Discontinued Operations (2016 - 2024)

Avanos Medical (AVNS) has 6 years of Liabilities from Discontinued Operations data on file, last reported at 52900000.0 in Q3 2024.

• For the quarter ending Q3 2024, Liabilities from Discontinued Operations rose 2016.0% year-over-year to 52900000.0; the trailing twelve-month figure through Sep 2024 stood at 52900000.0 (up 2016.0% YoY), and the FY2023 full-year result was 63700000.0, up 797.18% from the prior year.
• Liabilities from Discontinued Operations held at 52900000.0 in Q3 2024, from 52700000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 63700000.0 in Q4 2023 to a low of 2500000.0 in Q3 2023.
• A 3-year average of 38516666.67 and a median of 52450000.0 in 2024 frame the typical range for Liabilities from Discontinued Operations.
• Across the five-year window, Liabilities from Discontinued Operations soared 797.18% in 2023 and surged 2016.0% in 2024, its largest moves.
• Tracing AVNS's Liabilities from Discontinued Operations over 3 years: stood at 7100000.0 in 2022, then soared by 797.18% to 63700000.0 in 2023, then declined by 16.95% to 52900000.0 in 2024.
• Business Quant data shows AVNS's Liabilities from Discontinued Operations at 52900000.0 in Q3 2024, 52700000.0 in Q2 2024, and 52200000.0 in Q1 2024.